According to Prof. Michael Baumann (UK Carl Gustav Carus, Dresden, Germany), Prof. Ann Barrett (University of East Anglia School of Medicine, Norwich, UK), Dr. Ole Nielsen (Aarhus University Hospital, Aarhus, Denmark) and Dr. Sren Bentzen (Gray Cancer Institute, Northwood, UK) there is a wealth of experimental and clinical data which indicates that cure rates decrease with increasing waiting time for radiotherapy. "Increasing demand without increasing the resources to match, results in patients' welfare being jeopardised", explained Prof. Baumann. "Increased waiting times can result in tumours growing beyond a 'curative size' or in tumours metastasising. For tumours to grow beyond a curable size takes weeks or even months", emphasised Prof. Baumann. "But in some countries waiting times of this length are not uncommon and urgent action needs to be taken if all patients are to have equal access to optimal care".
In very few EU countries do the number of linear accelerators (machines used to deliver radiotherapy) match the number known to be required to adequately provide treatment. In those few countries with national guidelines to govern the numbers of linear accelerators per head of population, none have achieved the target set out in the guidelines.
Prof. Baumann cited the example of the U.K and the Netherlands where calls for increased investment in radiotherapy (provision of equipment and training of s
'"/>
Contact: Stuart Bell
stuart@fecs.be
32-2-775-0207
Federation of European Cancer Societies
26-Oct-2004